StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300915.SZ$23.09-4.78%
Fair $23.09+0.0%

300915.SZ

Shanghai Hi-Road Food Technology Co., Ltd.

Consumer Defensive / Packaged FoodsShenzhen

$23.09

-1.16 (-4.78%)

Fairly Valued+0.0%Fair Value $23.09Fund rank 26/100 · Data gapFallback financials|
SA 25/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-93.7M · quality 49.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

25/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -1.2%, below the 5% threshold
Thesis & Journal · 300915.SZLocal privado en este navegador · Shanghai Hi-Road Food Technology Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.9B

P/E

N/A

•

EV/EBITDA

277.1x

↑

ROE

-1.2%

↓

Gross Margin

24.5%

↓

Debt/Equity

0.03

↓
52-Week Range$23
$22$33

TradingView lightweight chart

300915.SZ price, volumen y niveles de valoración

Último $24.25Periodo -64.5%
Fair value: $23.09

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+4.8%

FCF CAGR

—

FCF margin

-15.0%

FCF / Net income

8.27x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $998.3M · net income $-18.1M · FCF $-149.8M

2022-FY → 2025-FY

Gross margin

24.5%-8.5% pts

Operating margin

-2.6%-10.8% pts

Net margin

-1.8%-12.6% pts

FCF margin

-15.0%-17.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$998.3M$998.3M$1.09B$954.6M$868.2M
Net Income$-18.1M$-18.1M$110.8M$89.5M$93.3M
EBITDA$9.3M$9.3M$158.2M$125.0M$125.5M
EPS-0.15-0.150.890.710.74
Gross Margin24.5%24.5%35.0%35.1%33.0%
Operating Margin-2.6%-2.6%10.0%8.8%8.2%
Net Margin-1.8%-1.8%10.2%9.4%10.7%
Balance Sheet
Debt/Equity0.030.030.040.040.04
Current Ratio7.717.71———
Cash Flow
Free Cash Flow$-149.8M$-149.8M$-48.5M$-93.7M$17.6M
Returns
ROE-1.2%-1.2%7.1%5.9%6.4%
Valuation
P/E——23.9732.1240.12
EV/EBITDA277.13277.1315.1718.9027.80
P/B1.971.971.711.912.58
Growth & Yield
Revenue Growth-8.2%-8.2%13.9%10.0%—
EPS Growth-116.9%-116.9%25.3%-4.1%—
Dividend Yield1.2%1.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -6.5%

Total return

-6.5%

Start / end P/E

n/dx → n/dx

EPS bridge

0.89 → -0.15

Residual

-7.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.2%
Residual / FX / buybacks / cross-term-7.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.